Article Information
History
- April 3, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 3, 2022 - 21:24).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ulrika Marking#,1,
- Sebastian Havervall#,1,
- Nina Greilert Norin1,
- Wanda Christ2,
- Max Gordon1,
- Henry Ng3,
- Kim Blom1,
- Mia Phillipson3,
- Sara Mangsbo4,
- Anna Smed Sörensen5,
- Peter Nilsson6,
- Sophia Hober6,
- Mikael Åberg*,7,
- Jonas Klingström*,2 and
- Charlotte Thålin*,1,¤
- 1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
- 2Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
- 3Department of Medical Cell Biology and SciLifeLab, Uppsala University, Uppsala, Sweden
- 4Department of Pharmacy and SciLifeLab, Uppsala University, Uppsala, Sweden
- 5Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 6Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
- 7Department of Medical Sciences, Clinical Chemistry and SciLifeLab, Uppsala University, Uppsala, Sweden
- ↵¤Corresponding author:
Charlotte Thålin, MD, PhD, Department of Clinical Sciences, Karolinska Insitutet Danderyd Hospital, 18288 Danderyd Hospital, Sweden, Phone: +46 8123 55000, Mail: charlotte.thalin{at}ki.se
Posted April 03, 2022.
